Cargando…
Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers
Phosphatases are proteins with the ability to dephosphorylate different substrates and are involved in critical cellular processes such as proliferation, tumor suppression, motility and survival. Little is known about their role in the different breast cancer (BC) phenotypes. We carried out micro-ar...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215587/ https://www.ncbi.nlm.nih.gov/pubmed/25201346 http://dx.doi.org/10.3892/ijo.2014.2648 |
_version_ | 1782342120904851456 |
---|---|
author | MANZANO, RAMON G. MARTINEZ-NAVARRO, ELENA M. FORTEZA, JERONIMO BRUGAROLAS, ANTONIO |
author_facet | MANZANO, RAMON G. MARTINEZ-NAVARRO, ELENA M. FORTEZA, JERONIMO BRUGAROLAS, ANTONIO |
author_sort | MANZANO, RAMON G. |
collection | PubMed |
description | Phosphatases are proteins with the ability to dephosphorylate different substrates and are involved in critical cellular processes such as proliferation, tumor suppression, motility and survival. Little is known about their role in the different breast cancer (BC) phenotypes. We carried out micro-array phosphatome profiling in 41 estrogen receptor-negative (ER(−)) BC patients, as determined by immunohistochemistry (IHC), containing both ERBB2(+) and ERBB2(−) in order to characterize the differences between these two groups. We characterized and confirmed the distinct phosphatome of the two main ER(−) BC subgroups (in two independent microarrays series) and that of ER(+) BC (in three large independent series). Our findings point to the importance of the MAPK and PI3K pathways in ER(−) BCs as some of the most differentially expressed phosphatases (like DUSP4 and DUSP6) sharing ERK as substrate, or regulating the PI3K pathway (INPP4B, PTEN). It was possible to identify a selective group of phosphatases upregulated only in the ER(−) ERBB2(+) subgroup and not in ER(+) (like DUSP6, DUSP10 and PPAPDC1A among others), suggesting a role of these phosphatases in specific BC subtypes, unlike other differentially expressed phosphatases (DUSP4 and ENPP1) that seemed to have a role in multiple BC subtypes. Significant correlation was found at the protein level by IHC between the expression of DUSP6 and phospho-ERK (p=0.04) but not of phospho-ERK with DUSP4. To show the potential prognostic relevance of phosphatases as a functional group of genes, we derived and validated in two large independent BC microarray series a multiphosphatase signature enriched in differentially expressed phosphatases, to predict distant metastasis-free survival (DMFS). ER(−) ERBB2(+), ER(−) ERBB2(−) and ER(+) BC patients have a distinct pattern of phosphatase RNA expression with a potential prognostic relevance. Further studies of the most relevant phosphatases found in this study are warranted. |
format | Online Article Text |
id | pubmed-4215587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-42155872014-10-31 Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers MANZANO, RAMON G. MARTINEZ-NAVARRO, ELENA M. FORTEZA, JERONIMO BRUGAROLAS, ANTONIO Int J Oncol Articles Phosphatases are proteins with the ability to dephosphorylate different substrates and are involved in critical cellular processes such as proliferation, tumor suppression, motility and survival. Little is known about their role in the different breast cancer (BC) phenotypes. We carried out micro-array phosphatome profiling in 41 estrogen receptor-negative (ER(−)) BC patients, as determined by immunohistochemistry (IHC), containing both ERBB2(+) and ERBB2(−) in order to characterize the differences between these two groups. We characterized and confirmed the distinct phosphatome of the two main ER(−) BC subgroups (in two independent microarrays series) and that of ER(+) BC (in three large independent series). Our findings point to the importance of the MAPK and PI3K pathways in ER(−) BCs as some of the most differentially expressed phosphatases (like DUSP4 and DUSP6) sharing ERK as substrate, or regulating the PI3K pathway (INPP4B, PTEN). It was possible to identify a selective group of phosphatases upregulated only in the ER(−) ERBB2(+) subgroup and not in ER(+) (like DUSP6, DUSP10 and PPAPDC1A among others), suggesting a role of these phosphatases in specific BC subtypes, unlike other differentially expressed phosphatases (DUSP4 and ENPP1) that seemed to have a role in multiple BC subtypes. Significant correlation was found at the protein level by IHC between the expression of DUSP6 and phospho-ERK (p=0.04) but not of phospho-ERK with DUSP4. To show the potential prognostic relevance of phosphatases as a functional group of genes, we derived and validated in two large independent BC microarray series a multiphosphatase signature enriched in differentially expressed phosphatases, to predict distant metastasis-free survival (DMFS). ER(−) ERBB2(+), ER(−) ERBB2(−) and ER(+) BC patients have a distinct pattern of phosphatase RNA expression with a potential prognostic relevance. Further studies of the most relevant phosphatases found in this study are warranted. D.A. Spandidos 2014-09-09 /pmc/articles/PMC4215587/ /pubmed/25201346 http://dx.doi.org/10.3892/ijo.2014.2648 Text en Copyright © 2014, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Articles MANZANO, RAMON G. MARTINEZ-NAVARRO, ELENA M. FORTEZA, JERONIMO BRUGAROLAS, ANTONIO Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers |
title | Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers |
title_full | Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers |
title_fullStr | Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers |
title_full_unstemmed | Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers |
title_short | Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers |
title_sort | microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the mapk and pi3k pathways in estrogen receptor-negative breast cancers |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215587/ https://www.ncbi.nlm.nih.gov/pubmed/25201346 http://dx.doi.org/10.3892/ijo.2014.2648 |
work_keys_str_mv | AT manzanoramong microarrayphosphatomeprofilingofbreastcancerpatientsunveilsacomplexphosphataseregulatoryroleofthemapkandpi3kpathwaysinestrogenreceptornegativebreastcancers AT martineznavarroelenam microarrayphosphatomeprofilingofbreastcancerpatientsunveilsacomplexphosphataseregulatoryroleofthemapkandpi3kpathwaysinestrogenreceptornegativebreastcancers AT fortezajeronimo microarrayphosphatomeprofilingofbreastcancerpatientsunveilsacomplexphosphataseregulatoryroleofthemapkandpi3kpathwaysinestrogenreceptornegativebreastcancers AT brugarolasantonio microarrayphosphatomeprofilingofbreastcancerpatientsunveilsacomplexphosphataseregulatoryroleofthemapkandpi3kpathwaysinestrogenreceptornegativebreastcancers |